Lund University Hospital
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 1768-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.skane.se/sus
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Phase 2
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT02958852
- Locations
- 🇸🇪
Lund University Hospital, Department of Oncology, Lund, Sweden
Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy
Not Applicable
Completed
- Conditions
- Relapsed Prostate Cancer
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02699424
- Locations
- 🇸🇪
Lund University Hospital, Lund, Sweden
Phantom Limb Pain: Efficacy of Non-invasive Sensory Feedback Through the Prosthesis
Not Applicable
Completed
- Conditions
- Phantom Limb Pain
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT02589080
- Locations
- 🇸🇪
Fredrik Sebelius, Lund, Sweden
A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Phase 2
Completed
- Conditions
- Relapsed/Refractory Mantle Cell Lymphoma
- Interventions
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT02460276
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇫🇮Helsinki University Hospital, Helsinki, Finland
🇳🇴Norwegian Radium Hospital, Oslo, Norway
Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.
- Conditions
- Tumor in Upper Gastrointestinal Canal or Patients With Colorectal Cancer
- First Posted Date
- 2014-09-23
- Last Posted Date
- 2021-05-18
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 108
- Registration Number
- NCT02246725
- Locations
- 🇸🇪
Lund University Hospital, Lund, Sweden
Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.
Phase 2
Completed
- Conditions
- Adenocarcinoma of the Esophagus or Esophagogastric Junction
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2014-09-16
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT02241499
- Locations
- 🇸🇪
Lund University Hospital, Department of Oncology, Lund, Sweden
Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia
- First Posted Date
- 2014-05-22
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT02144623
- Locations
- 🇸🇪
Lund University Hospital, Department of Oncology, Lund, Sweden
The Swedish Study on Paleolithic Diet for Type 2 Diabetes
Not Applicable
Withdrawn
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2013-12-03
- Last Posted Date
- 2018-08-16
- Lead Sponsor
- Lund University Hospital
- Registration Number
- NCT01999452
- Locations
- 🇸🇪
Center for Primary Health Care Research, Clinical Research Centre (CRC), hus 28, plan 11, Jan Waldenströms gata 35, Malmö, Skåne, Sweden
A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.
Phase 3
Completed
- Conditions
- Locally Advanced Head and Neck Cancer
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 298
- Registration Number
- NCT01969877
- Locations
- 🇸🇪
Gävle Hospital, Gävle, Sweden
🇸🇪Sahlgrenska University Hospital, Göteborg, Sweden
🇸🇪County Hospital Ryhov, Jönköping, Sweden
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Not Applicable
Completed
- Conditions
- Intracranial Tumor
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Lund University Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT01674582
- Locations
- 🇸🇪
Lund University Hospital, Lund, Sweden